fashion -WSS

fashion

author：fashion 2025-09-30 11:15:11 - browse：374

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Drug for rare kidney disease narrowly misses mark in clinical trial

hotspot

WSS

Diversity in medical illustrations gets boost from Chidiebere Ibe

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Study finds new variant for Parkinson’s in African populations

Drug for rare kidney disease narrowly misses mark in clinical trial

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Senate HELP committee spars over health care workforce policies

hotspot

fashion

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

It's been 20 years since Dolly the sheep. Where's my clone?

Apple is now the first public company to be valued at $3 trillion

Thermo Fisher plant for manufacturing gene therapies to expand

Heart attack and stroke risk calculators need revising

What Congress can do to address the rural doctor shortage

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical student insurance fails on mental health care coverage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Departing Stanford president retracts two papers

hotspot

In science, is the line between industry and academia shifting?

How Long Island became the ‘eugenics capital of the world’

AstraZeneca bets AAV gene therapy will still deliver the goods

Drug for rare kidney disease narrowly misses mark in clinical trial

It's been 20 years since Dolly the sheep. Where's my clone?

Microbiome research is starting to find links to chronic diseases

focus

hotspot

hotspot

focus